November 4, 2025

VUMC performs minimally invasive transcatheter tricuspid valve replacement for recent heart transplant recipient

The team used an artificial tricuspid valve, EVOQUE, which received Food and Drug Administration approval in February.

By Jill Clendening

October 28, 2021

The challenge of rejection

Minimizing variation in how rejection is diagnosed and creating standardized surveillance protocols may help inform best practices in pediatric heart transplants.

By Shivani Sharma

August 12, 2020

Congenital heart patient receives unexpected transplant

For years, doctors told Piper Davis it was impossible to have a heart transplant. She was born with just one ventricle, or pumping chamber, instead of two. A generation ago, such patients didn’t survive into adulthood.

By Matt Batcheldor

May 2, 2019

More congenital heart patients becoming transplant candidates

Patients with a form of congenital heart disease — having only one ventricle (pumping chamber) — are now living longer lives due to the successful surgical and medical treatments they receive as children.

By Matt Batcheldor

August 23, 2018

Novel program gives congenital heart disease patients new options

Experts at the Vanderbilt Heart and Vascular Institute are forging new ground in the development of a first-of-its-kind program aimed at adults with congenital heart disease (ACHD).

By Jessica Pasley

July 12, 2018

Transplant Center leads way in using hearts from hepatitis C donors

Medical teams at the Vanderbilt Transplant Center (VTC) are leading the way in utilization of hepatitis C-exposed donors for heart transplantation.

By Jessica Pasley